Literature DB >> 12713822

Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria.

Norman S Radin1.   

Abstract

Published reports are reviewed as the basis of a proposal that an effective antineoplastic drug should contain several features: (a) resemblance to the natural lipid, ceramide; (b) an allylic alcohol and/or allylic ketone moiety; (c) a hydroxyl and/or a nitrogen atom near the allylic group; (d) conjugated double bonds as part of the allylic region. The drug should produce reactive oxygen species in tumor mitochondria, stimulate the generation of ceramide in the tumor, and condense with mitochondrial glutathione. It is pointed out that some antibiotics with these features are also active against cancer cells; perhaps anticancer drugs with these features will prove useful as antibiotics. Common problems in working with lipoidal substances are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713822     DOI: 10.1016/s0968-0896(02)00609-0

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.

Authors:  Thomas H Beckham; Saeed Elojeimy; Joseph C Cheng; Lorianne S Turner; Stanley R Hoffman; James S Norris; Xiang Liu
Journal:  Expert Opin Ther Targets       Date:  2010-05       Impact factor: 6.902

2.  Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π.

Authors:  Wen-Ying Chen; Yu-An Hsieh; Ching-I Tsai; Ya-Fei Kang; Fang-Rong Chang; Yang-Chang Wu; Chin-Chung Wu
Journal:  Invest New Drugs       Date:  2010-08-05       Impact factor: 3.850

Review 3.  Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer.

Authors:  S M Hadi; M F Ullah; A S Azmi; A Ahmad; U Shamim; H Zubair; H Y Khan
Journal:  Pharm Res       Date:  2010-01-30       Impact factor: 4.200

4.  Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice.

Authors:  F Dahm; A Bielawska; A Nocito; P Georgiev; Z M Szulc; J Bielawski; W Jochum; D Dindo; Y A Hannun; P-A Clavien
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.